Drug Re-Purposing Webinar 1 - Shared screen with speaker view
Megha, we can’t hear you well…
Megha, we can't hear you very well.
We can't hear Megha
cannot hear megha very well
Canada Viagra patent - invalidation, is that for failing a Canadian equivalent of "best mode" in USA?
In the case of Pregabalin, would a change in dosage or formulation have change the issue with the 2nd medical use patent and the skinny label bypass?
Didn’t the law change allowing publication of data by authors before patent filing?
Not repurposing exactly - but do you have any comments on the recent rulings on Vascepa?
Another repurposed strategy to discuss, using the Celgene thalidomide model.
Do you confirm that once an academic lab published some preclinical data on a potentially repurposable molecules, nothing can be done anymore? or could more in-depth preclinical validation be considered as « novel-enough »?
if I find a compound (X) which has good efficacy alone, but one company patented another compound (Y) and showed an example of using Y with a conjugate of our compound like Y-X, can we still patent it, X?
If you have a discovery based on a re-purposed compound as well as novel compounds that work against the same target but have better properties (in terms of potency, solubility etc), do you have suggestions for the best way to pursue patent protection?
CAn changing excipient ratios in a formulation classify as novel?
Sorry I will try to speak up more
Thank you very much! excellent presentation!
Very helpful, thank you!
Thanks! Very insightful